Skip to main content

Table 3 Comparison of mpMRI and bpMRI for diagnosing prostate lesions

From: Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer

 

mpMRI

bpMRI

P

<  4 (n = 98)

≥ 4 (n = 137)

<  4 (n = 107)

≥ 4 (n = 128)

Non-PCa, n (%)

79 (80.6)

34 (24.8)

82 (76.6)

31 (24.2)

 

PCa, n (%)

19 (19.4)

103 (75.2)

25 (23.4)

97 (75.8)

Accuracy

 

77.4 (71.7–82.3)

 

76.2 (70.3–81.2)

 

Sensitivity

 

84.4 (76.8–90.4)

 

79.5 (71.3–86.3)

 

Specificity

 

69.9 (60.6–78.2)

 

72.6 (63.4–80.5)

 

PPV

 

75.2 (67.1–82.2)

 

75.8 (67.4–82.9)

 

NPV

 

80.6 (71.3–87.9)

 

76.6 (67.5–84.3)

 

AUC

 

0.791 (0.733–0.841)

 

0.790 (0.732–0.840)

0.760*

Non-csPCa, n (%)

86 (87.8)

50 (36.5)

91 (85.0)

45 (35.2)

 

csPCa, n (%)

12 (12.2)

87 (63.5)

16 (15.0)

83 (64.8)

 

Accuracy

 

73.6 (67.6–78.9)

 

74.0 (68.1–79.2)

 

Sensitivity

 

87.9 (79.8–93.6)

 

83.8 (75.1–90.5)

 

Specificity

 

63.2 (54.5–71.3)

 

66.9 (58.3–74.7)

 

PPV

 

63.2 (54.9–71.6)

 

64.8 (55.9–73.1)

 

NPV

 

87.8 (79.6–93.5)

 

85.0 (76.8–91.2)

 

AUC

 

0.779 (0.721–0.831)

 

0.781 (0.722–0.832)

0.753*

  1. The accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) are presented as (%, [95% confidence interval]); the areas under the curve (AUCs) are presented with 95% confidence intervals
  2. *Delong test was used to compare the AUCs of bpMRI and mpMRI